Open access
266
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Development of an Effective Neutralizing Antibody Assay for SARS-CoV-2 Diagnosis
Zhigang Liu1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of ChinaView further author information
, Jiahui Liang1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of China
https://orcid.org/0000-0003-3183-3198View further author information
Hangzhan Hu1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of ChinaView further author information
, Mengli Wu1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of ChinaView further author information
, Jingjing Ma1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of ChinaView further author information
, Ziwei Ma1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of China
https://orcid.org/0000-0001-9671-3520View further author information
Jianing Ji1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of ChinaView further author information
, Hengyi Chen2 Center of Smart Laboratory and Molecular Medicine, Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing, 400044, People’s Republic of ChinaView further author information
, Xiaoquan Li1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of ChinaView further author information
, Zhizeng Wang1 Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, 475004, People’s Republic of China;2 Center of Smart Laboratory and Molecular Medicine, Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing, 400044, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0003-4847-948XView further author information
Yang Luo2 Center of Smart Laboratory and Molecular Medicine, Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing, 400044, People’s Republic of China;3 College of Life Science and Laboratory Medicine, Kunming Medical University, Kunming, 650500, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 3125-3139
|
Received 23 Feb 2023, Accepted 08 Jun 2023, Published online: 12 Jun 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.